UMIN-CTR Clinical Trial

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000040805
Receipt No. R000046548
Scientific Title Chlorohexidine gluconate rubbing for prevention of wound infection: A randomized controlled trial.
Date of disclosure of the study information 2020/06/20
Last modified on 2020/12/17 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Chlorohexidine gluconate rubbing for prevention of wound infection: A randomized controlled trial.
Acronym Chlorohexidine gluconate rubbing for prevention of wound infection: A randomized controlled trial.
Scientific Title Chlorohexidine gluconate rubbing for prevention of wound infection: A randomized controlled trial.
Scientific Title:Acronym SSI CHG rubbing study
Region
Japan

Condition
Condition Surgical site infection
Classification by specialty
Surgery in general
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To clarify the efficacy of chlorhexidine gluconate rubbing to prevent wound infection.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes The incidence of wound infection during postoperative 30 days.
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Single blind -participants are blinded
Control No treatment
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 Subcutaneous disinfection by Chlorohexidine gluconate rubbing.
Interventions/Control_2 Without subcutaneous disinfection.suturing
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1.The age is older than 20 years of age.
2.Surgery for gastrointestinal, including emergency
3.The parson that a document agreement by the free was provided after enough understanding after having received enough explanation on participating to this study
Key exclusion criteria 1.Surgery with wound classification classI
2.Patients judged by investigators ineligible.
Target sample size 370

Research contact person
Name of lead principal investigator
1st name Hiroyuki
Middle name
Last name Sugo
Organization Juntendo Nerima Hospital
Division name Department of general surgery
Zip code 1778521
Address 3-1-10 Takanodai Nerima Tokyo
TEL 03-5923-3111
Email h.sugou@juntendo-nerima.jp

Public contact
Name of contact person
1st name Shigefumi
Middle name
Last name Neshime
Organization Juntendo Nerima Hospital
Division name Department of general surgery
Zip code 1778521
Address 3-1-10 Takanodai Nerima Tokyo
TEL 03-5923-3111
Homepage URL
Email s.neshime@juntendo-nerima.jp

Sponsor
Institute Juntendo Nerima Hospital
Institute
Department

Funding Source
Organization Juntendo Nerima Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Juntendo Nerima Hospital GCP center
Address 3-1-10 Takanodai Nerima Tokyo
Tel 03-5923-3111
Email gcp@juntendo-nerima.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 06 Month 20 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2020 Year 06 Month 05 Day
Date of IRB
2020 Year 07 Month 07 Day
Anticipated trial start date
2020 Year 08 Month 01 Day
Last follow-up date
2024 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2020 Year 06 Month 17 Day
Last modified on
2020 Year 12 Month 17 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000046548